Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 17, 2015 09:00 ET | Source: Coherus BioSciences, Inc.

Coherus Finalizes CHS-1701 BLA Enabling Clinical Program and Initiates Pivotal Pharmacokinetic and Pharmacodynamic Study

REDWOOD CITY, Calif., March 17, 2015 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), a leading pure-play, global biosimilars company with late-stage clinical products, today announced...
March 16, 2015 09:00 ET | Source: Coherus BioSciences, Inc.

Coherus BioSciences to Report Fourth Quarter and Year End 2014 Financial Results on March 23

REDWOOD CITY, Calif., March 16, 2015 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), a late-stage clinical biologics platform company focused on the global biosimilar market, today...
February 23, 2015 18:00 ET | Source: Coherus BioSciences, Inc.

Coherus BioSciences to Present at Cowen and Company Health Care Conference on March 2

REDWOOD CITY, Calif., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), a late-stage clinical biologics platform company focused on the global biosimilar market, today...
February 04, 2015 16:00 ET | Source: Coherus BioSciences, Inc.

Coherus BioSciences to Present at Leerink Healthcare Conference on February 11

REDWOOD CITY, Calif., Feb. 4, 2015 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), a late-stage clinical biologics platform company focused on the global biosimilar market, today...
December 15, 2014 16:05 ET | Source: Coherus BioSciences, Inc.

Coherus BioSciences Reports Third Quarter 2014 Financial and Operating Results

REDWOOD CITY, Calif., Dec. 15, 2014 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), a late-stage clinical biologics platform company focused on the global biosimilar market, today...
December 08, 2014 09:00 ET | Source: Coherus BioSciences, Inc.

Coherus BioSciences to Present at the J.P. Morgan Healthcare Conference on January 12

REDWOOD CITY, Calif., Dec. 8, 2014 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), a late-stage clinical biologics platform company focused on the global biosimilar market, today...
December 04, 2014 16:05 ET | Source: Coherus BioSciences, Inc.

Coherus BioSciences to Host Earnings Conference Call on December 15

REDWOOD CITY, Calif., Dec. 4, 2014 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), a late-stage clinical biologics platform company focused on the global biosimilar market, today...
November 12, 2014 18:59 ET | Source: Coherus BioSciences, Inc.

Coherus BioSciences Announces Closing of Initial Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares

REDWOOD CITY, Calif., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. announced today the closing of its initial public offering of 6,803,702 shares of its common stock at a public...
November 06, 2014 11:52 ET | Source: Coherus BioSciences, Inc.

Coherus BioSciences Prices Initial Public Offering of $85 Million of Common Stock

REDWOOD CITY, Calif., Nov. 6, 2014 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS) announced today the pricing of its initial public offering of 6,296,300 shares of its common stock at a...